| Website | mpexpharma.com |
| Category | BioTech |
| Phone | 858-875-2840 |
| info@mpexpharma.com | |
| Employees |
| TOTAL | $32M |
| FUNDING TOTAL | $32M |
| Series B, 8/05 SV Life Sciences HBM BioVentures Aberdare Ventures Adams Street Partners Western States Investment Group Charitable Leadership Foundation | $32M |
Mpex Pharmaceuticals is a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, with a particular focus on gram-negative organisms. The Company’s internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.
